Isabel Hinse-Faust
Bad Oeynhausen, NW 32545, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Xylosyltransferase-I serum activity is a promising biomarker for postmenopausal osteoporosis.
Journal: Scientific reports
Published: May 18, 2026
XYLT1 Deficiency of Human Mesenchymal Stem Cells: Impact on Osteogenic, Chondrogenic, and Adipogenic Differentiation.
Journal: International journal of molecular sciences
Published: June 20, 2025
Xylosyltransferase-Deficiency in Human Dermal Fibroblasts Induces Compensatory Myofibroblast Differentiation and Long-Term ECM Reduction.
Journal: Biomedicines
Published: January 30, 2024
Human Xylosyltransferase I-An Important Linker between Acute Senescence and Fibrogenesis.
Journal: Biomedicines
Published: December 29, 2022
The Human Myofibroblast Marker Xylosyltransferase-I: A New Indicator for Macrophage Polarization.
Journal: Biomedicines
Published: September 29, 2022
The Consideration of Pseudoxanthoma Elasticum as a Progeria Syndrome.
Journal: Frontiers in bioscience (Landmark edition)
Published: July 27, 2022
First Characterization of Human Dermal Fibroblasts Showing a Decreased Xylosyltransferase-I Expression Induced by the CRISPR/Cas9 System.
Journal: International journal of molecular sciences
Published: April 06, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026